1. Home
  2. NVNO vs NEUE Comparison

NVNO vs NEUE Comparison

Compare NVNO & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • NEUE
  • Stock Information
  • Founded
  • NVNO 1987
  • NEUE 2015
  • Country
  • NVNO United States
  • NEUE United States
  • Employees
  • NVNO N/A
  • NEUE N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • NEUE
  • Sector
  • NVNO Health Care
  • NEUE
  • Exchange
  • NVNO Nasdaq
  • NEUE NYSE
  • Market Cap
  • NVNO 71.0M
  • NEUE 61.3M
  • IPO Year
  • NVNO N/A
  • NEUE 2021
  • Fundamental
  • Price
  • NVNO $4.96
  • NEUE $6.77
  • Analyst Decision
  • NVNO
  • NEUE Hold
  • Analyst Count
  • NVNO 0
  • NEUE 1
  • Target Price
  • NVNO N/A
  • NEUE $7.00
  • AVG Volume (30 Days)
  • NVNO 137.7K
  • NEUE 5.1K
  • Earning Date
  • NVNO 08-04-2025
  • NEUE 08-07-2025
  • Dividend Yield
  • NVNO N/A
  • NEUE N/A
  • EPS Growth
  • NVNO N/A
  • NEUE N/A
  • EPS
  • NVNO N/A
  • NEUE N/A
  • Revenue
  • NVNO N/A
  • NEUE $907,349,000.00
  • Revenue This Year
  • NVNO N/A
  • NEUE $33.99
  • Revenue Next Year
  • NVNO N/A
  • NEUE $5.90
  • P/E Ratio
  • NVNO N/A
  • NEUE N/A
  • Revenue Growth
  • NVNO N/A
  • NEUE N/A
  • 52 Week Low
  • NVNO $2.03
  • NEUE $3.79
  • 52 Week High
  • NVNO $5.92
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 62.60
  • NEUE 44.13
  • Support Level
  • NVNO $4.72
  • NEUE $6.73
  • Resistance Level
  • NVNO $5.13
  • NEUE $6.88
  • Average True Range (ATR)
  • NVNO 0.38
  • NEUE 0.09
  • MACD
  • NVNO 0.06
  • NEUE -0.01
  • Stochastic Oscillator
  • NVNO 61.85
  • NEUE 18.18

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Share on Social Networks: